Preset protocols
Compare protocols →Browse 15 preset examples and open them in the plotter. These are not treatment recommendations. Only available models produce curves; a selected horizon does not establish steady state. Compare preset models or read the model assumptions and limitations.
Semaglutide Titration (20 weeks)
FDA Wegovy label titration: 0.25 → 0.5 → 1.0 → 1.7 → 2.4 mg weekly, escalating every 4 weeks to the 2.4mg maintenance dose.
Tirzepatide Titration (24 weeks)
FDA Zepbound label titration: 2.5 → 5 → 7.5 → 10 → 12.5 → 15 mg weekly, escalating every 4 weeks to the 15mg maintenance dose.
Retatrutide Protocol (24 weeks)
Investigational triple-agonist (GLP-1/GIP/glucagon) Phase 2 trial titration: 2 → 4 → 8 → 12 mg weekly, escalating every 4 weeks to the 12mg maintenance dose.
Wolverine Stack
Popular healing/repair stack pairing BPC-157 with TB-500 for soft-tissue and recovery support.
Skin GLOW Stack
Comprehensive skin-and-recovery blend (GHK-Cu + TB-500 + BPC-157 + KPV) dosed daily for collagen, healing, and anti-inflammatory support. Based on the GLOW/Upgraded-Glow blend ratios.
Mito Stack
Sequenced mitochondrial protocol: SS-31 (elamipretide) 4mg daily for the first 6 weeks, then MOTS-c 5mg 3×/week for the following 8 weeks. Modeled on the documented SS-31/MOTS-c cycling protocol.
Cognitive Duo
Two-peptide cognitive stack pairing the nootropics Semax and Selank. Short 4-week cycle (Semax/Selank are cycled 10–30 days on, then 1–2 weeks off).
HGH Fragment 176-191 (lipolytic)
Lipolytic HGH fragment (AOD-9604) studied for fat loss without the growth effects of full-length HGH.
Epitalon Anti-Aging (10-day cycle)
Short telomerase-activating cycle: 5mg Epitalon daily for 10 days, repeated every 6 months. The most widely documented Epitalon protocol across Russian, Ukrainian, and Western sources.
Tesamorelin (Visceral Fat)
GHRH analog approved for HIV-associated lipodystrophy. 2mg daily subcutaneous for visceral fat reduction — the documented clinical dose, typically run 12–26 weeks.
Thymosin Alpha-1 (Immune Support)
Immune-modulating peptide: 1.6mg twice weekly for immune support. Documented across peptide guides for its immunomodulatory role.
BPC-157 + TB-500 Healing Blend
The popular pre-mixed healing blend reconstituted as a protocol: daily BPC-157 with weekly TB-500 for soft-tissue and recovery support.
CJC-1295 + Ipamorelin Blend
Common secretagogue blend reconstituted as a protocol: GHRH (CJC-1295 no DAC) + GHRP (ipamorelin) dosed together 3×/week for synergistic GH release.
Comprehensive Healing Blend (4-Peptide)
Long-course healing + recovery blend (TB-500 + BPC-157 + KPV + GHK-Cu) dosed daily. A 2-week intro at half dose to assess tolerance, then 10 weeks at the standard dose. Modeled on documented blend ratios.
CagriSema Titration (Cagrilintide + Semaglutide)
Investigational CagriSema combination (REDEFINE trial) — 16-week parallel titration of cagrilintide + semaglutide dosed weekly to the 2.4/2.4mg maintenance target.